ArticleCureus2026
Eosinophilic Esophagitis Revealed by Hematemesis in an Asthmatic Adolescent: A Case Report.
Article in Cureus, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Eosinophilic esophagitis (EoE) is a chronic inflammatory condition of the esophagus, with increasing prevalence and incidence, characterized by eosinophilic infiltration of the mucosa, and frequently associated with asthma and atopic predisposition. We report the case of a 13-year-old female patient with poorly controlled moderate persistent asthma, admitted for recurrent vomiting over the past year, complicated by the sudden onset of hematemesis, associated with fever and clinical deterioration. On admission, the patient presented with tachycardia, hypoxemia, and acute respiratory distress associated with an asthma exacerbation. An emergency esophagogastroduodenoscopy revealed EoE, with histopathology demonstrating dense eosinophilic infiltration (>15 eosinophils/high-power field). Allergy testing revealed food sensitization to prawns. Treatment with oral fluticasone (250 μg twice daily) combined with double-dose proton pump inhibitors resulted in rapid clinical remission and complete histological normalization at 10 months. This case highlights the need to systematically consider EoE in the presence of any acute gastrointestinal symptoms in a patient with atopic predisposition, and the importance of early management.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.